Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial

Table 3 SSCP score before and after the intervention

	Educational lecture group				Contact-based intervention group
	n = 56				n = 59
	Baseline	Post-test	p^a	Difference	Baseline	Post-test	p^a	Difference	p^b	Effect size
SSCP, median (inter-quartile range)	74.0 (67.0–82.0)	69.0 (64.3–77.8)	< 0.001	−3.0 (−7.0–1.0)	71.0 (66.0–80.0)	62.0 (54.0–67.0)	< 0.001	−9.0 (−16.0−−5.0)	< 0.001	0.41
Factor I, median (inter-quartile range)	32.0 (29.0–37.0)	29.5 (26.0–35.0)	< 0.001	−1.0 (− 5.0–0)	31.0 (26.0–36.0)	25.0 (22.0–30.0)	< 0.001	−4.0 (−9.0−−2.0)	0.001	0.32
Factor II, median (inter-quartile range)	20.0 (18.0–22.0)	18.0 (17.0–21.8)	0.02	−1.0 (− 2.8–1.0)	20.0 (18.0–22.0)	16.0 (12.0–18.0)	< 0.001	−5.0 (−7.0−−2.0)	< 0.001	0.49
Factor III, median (inter-quartile range)	12.0 (9.0–14.0)	11.0 (9.0–13.0)	0.01	−1.0 (−2.0–0)	11.0 (9.0–13.0)	10.0 (8.0–12.0)	0.04	−1.0 (−2.0–1.0)	0.94	0.01
Factor IV, median (inter-quartile range)	10.0 (9.0–11.8)	10.0 (9.0–11.0)	0.52	0.0 (−1.0–1.0)	10.0 (8.0–12.0)	9.0 (8.0–10.0)	0.35	0.0 (−1.0–1.0)	0.18	0.13

^a: vs. each baseline
^b: vs. Lecture group
Factor I: social distance at professional pharmacy service
Factor II: attitudes towards patients diagnosed with schizophrenia
Factor III: self-disclosure
Factor IV: social distance in personal
Statistical analysis was performed using the Wilcoxon signed-rank test or Mann-Whitney U test

ISSN: 1471-244X